Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02983786 · ClinicalTrials.gov registry record
Detection of Cerebral Ischemia With a Noninvasive Neurometabolic Optical Monitor
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 29
- Enrollment target
NCT02983786: Completed study, sponsored by University of Pennsylvania.
NCT02983786 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 29 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02983786 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 29 participants
- Enrollment target
Study Summary
The goals of the project are to evaluate a noninvasive monitor of brain metabolism and blood flow in critically ill humans. If validated, such a reliable noninvasive brain blood flow and metabolism monitor, by allowing physiologic and pharmacologic decisions based on real-time brain physiology, potentially will become an important tool for clinicians in their efforts to prevent additional brain tissue death in patients admitted with stroke, brain hemorrhage and traumatic brain injury.
Primary Outcome
Determine if the optical monitoring device's assessment of CBF is valid.
Interventions
- DRUG Indocyanine Green
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2015-12 |
| Est. Completion | 2022-05-25 |
What the finished NCT02983786 record still lists
NCT02983786 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 29 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Indocyanine Green is the first listed.
NCT02983786 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02983786 about?
NCT02983786 is a clinical study titled "Detection of Cerebral Ischemia With a Noninvasive Neurometabolic Optical Monitor". The goals of the project are to evaluate a noninvasive monitor of brain metabolism and blood flow in critically ill humans. If validated, such a reliable noninvasive brain blood flow and metabolism monitor, by allowing physiologic and pharmacologic decisions based on real-time brain physiology, pote...
What is the current status of trial NCT02983786?
This trial is currently completed. The enrollment target is 29 participants. The study started on 2015-12. Estimated completion is 2022-05-25.
What interventions are being tested in trial NCT02983786?
The interventions under investigation include: Indocyanine Green (DRUG).
Who is sponsoring clinical trial NCT02983786?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02429557 · 29 participants · Phase 1
Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure
- NCT02568878 · 29 participants · Phase 3
Creatine for Depressed Male and Female Methamphetamine Users
- NCT03014401 · 29 participants · NA
The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis
- NCT03128996 · 29 participants · Phase 1
Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia